Sensitise public on alert against Coldrif cough syrup batch: Telangana govt directs health officials
Hyderabad: The Director of Public Health, Telangana, has instructed all District Medical and Health Officers (DM&HOs) to actively sensitise the public about the alert, which was originally issued on September 4 by the Drugs Control Administration (DCA). The directive emphasizes the need to stop the use of Coldrif syrup of Batch No. SR-13, which has been allegedly found adulterated with Diethylene Glycol (DEG), a toxic substance.
If people are in possession of the syrup, they should immediately report to the local drug control authority on its toll free number, the communication (dated October 5), shared with the media on Monday, said.
The Director of Public Health also asked DM&HOs to strictly implement and disseminate the advisory issued by the Directorate General of Health Services (DGHS), Union Ministry of Health, regarding the judicious prescribing and dispensing of cough syrups for children.
The DGHS, in the advisory, stated that most acute cough illnesses in children are self-limiting and often resolve without pharmacological intervention.
Cough and cold medications should not be prescribed or dispensed to children under two years. They are generally not recommended for ages below five years, and above that, any use should follow careful clinical evaluation with close supervision and strict adherence to appropriate dosing and other relevant precautions.
As per PTI, the advisory also said all healthcare facilities and clinical establishments must ensure procurement and dispensing of products manufactured under Good Manufacturing Practices and formulated with pharmaceutical-grade excipients.
The Madhya Pradesh government on October 4 banned the sale of Coldrif syrup following the death of nine children due to suspected kidney infection in Chhindwara district since September 7.
Next Story